Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ACC 26: FAST III - FFR vs vFFR to Guide Revascularisation
Author(s): Joost Daemen Added: 1 month ago
American College of Cardiology Congress 2026 - Dr Joost Daemen (Thoraxcenter, Erasmus University Medical Center, Rotterdam, NL) joins us to discuss findings from the FAST III trial (NCT04931771; ECRI) a large-scale randomised study comparing fractional flow reserve (FFR) with 3D-quantitative coronary angiography-derived vessel FFR (vFFR) to guide coronary revascularisation.This randomised, open… View more

Intervention
Added: 1 month ago Source:  Interventional Cardiology Review Journal
Long-term follow-up from the FAMOUS-NSTEMI trial suggests that a fractional flow reserve-guided strategy for managing patients with non-ST-segment elevation myocardial infarction (NSTEMI) does not reduce adverse cardiovascular outcomes compared to standard angiography-guided care.¹MethodologyFAMOUS-NSTEMI was a prospective, randomised, controlled trial that enrolled 350 patients with NSTEMI… View more

Intervention

MI/ACS
Added: 3 months ago Source:  Radcliffe Cardiology
The long-term benefits of revascularization over medical therapy for patients with stable coronary artery disease (CAD) remain a subject of clinical debate. New long-term follow-up data from the Fractional Flow Reserve versus Angiography for Multivessel Evaluation 2 (FAME 2) trial provide further insight, demonstrating a sustained benefit for percutaneous coronary intervention (PCI) guided by… View more

Guidelines & Statements

Intervention
ESC 24: NOTION-3: FFR Guided PCI in TAVI
Author(s): Jacob Thomsen Lønborg Added: 1 year ago
ESC Congress 2024 — FFR-guided PCI improves outcomes in TAVI patients with coronary artery disease.Principal investigator, Prof Jacob Thomsen Lønborg (Rigshospitalet, DK) joins us to discuss the NOTION-3 trial (NCT03058627). A multinational, open-label, investigator-initiated trial evaluated the efficacy of FFR-guided PCI versus medical therapy in managing coronary artery disease (CAD) among… View more

Imaging & Diagnostics

Intervention
FFR-Guided PCI Lowers MACE vs Angiography
Added: 6 months ago Source:  Transcatheter Academy
An individual patient data (IPD) meta-analysis has found that using fractional flow reserve (FFR) to guide percutaneous coronary intervention (PCI) is associated with a significant reduction in major adverse events compared to a standard angiography-guided strategy. The benefit appears to be driven primarily by a reduction in peri-procedural myocardial infarction (MI).¹The PRIME Collaboration… View more

Guidelines & Statements

Intervention
Research Area(s) / Expertise: Job title: Head, Department of Invasive Cardiology, CSK MSWiA, Warsaw, Poland
Robert Gil is Head of the Department of Invasive Cardiology of the Clinical Hospital of the Ministry of the Interior and Administration (MSWiA) in Warsaw, Poland, a position he has held since 2001. Graduating from the Pomeranian Medical University in Szczecin, since 2001 Prof Gil has been part of the Expert Team handling accreditation in cardiology, as appointed by the Polish Minister of… View more
llateral Flow Linked to Reduced Angina Pain in CAD
Added: 5 months ago Source:  Radcliffe Cardiology
A study has found that while the severity of ischaemia correlates poorly with daily angina symptoms in patients with stable coronary artery disease (CAD), the development of coronary collateral circulation is associated with both the ischaemic burden and reduced intensity of ischaemic chest pain.¹ This may help explain the often-observed disconnect between stenosis severity and patient-reported… View more

Demographic

Intervention
Kelvin Lee
Job title: Consultant Interventional Cardiologist
Prof Kelvin Lee is Consultant Interventional Cardiologist at the Lincolnshire Heart Centre with a focus on complex coronary intervention. His expertise includes intra-coronary imaging, rotational atherectomy, intravascular lithotripsy and coronary physiology using iFR and FFR. He leads the Cardiovascular Clinical Research Programme and is Cardio-Metabolic Lead and Deputy Clinical Director of… View more
Complete Revascularisation in STEMI: Do We Really Buy It?
Author(s): Tevin Browne , Richard J Jabbour , Nick Curzen Added: 1 week ago

Imaging & Diagnostics

Intervention
iMODERN: No Benefit for Immediate Nonculprit-Lesion PCI
Added: 2 months ago Source:  ICR3 Journal Radcliffe Cardiology
The optimal timing for treating nonculprit lesions in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease remains a topic of clinical debate. The iMODERN trial sought to clarify this by comparing outcomes between an immediate, physiology-guided percutaneous coronary intervention (PCI) strategy and a deferred, imaging-guided approach.¹˒²MethodologyThe… View more

Intervention

MI/ACS